Although lower price playing cards can help alleviate the burden of superior drug costs within the short-term, they don't deal with the systemic challenges driving up prescription price ranges during the U.S. Broader plan improvements could tackle the root leads to of rising drug rates, such as lack of transparency in pricing and the role of interm